Ranked by reported Q3 2025 13F market value
Share of total reported institutional value in BCLI held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ADVISOR GROUP HOLDINGS, INC. | 2K | $1K | -6.8% | 0.016% | 0.00% |
| 2 | Bangor Savings Bank | 266 | $188 | 0.0% | 0.002% | 0.00% |
| 3 | VSM Wealth Advisory, LLC | 120 | $85 | 0.0% | 0.001% | 0.00% |
| 4 | Steward Partners Investment Advisory, LLC | 113 | $80 | 0.0% | 0.001% | 0.00% |
| 5 | ST GERMAIN D J CO INC | 33 | $23 | 0.0% | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in BCLI — a direct measure of their conviction.
Filings activity in BCLI during Q3 2025, grouped by how each filer changed its position.
Institutions that opened a new BCLI position in Q3 2025
No new institutional buyers this quarter.
Institutions that fully closed their BCLI position in Q3 2025
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q3 2025 | 5 | 86% | 0.02% | 3.20 pp | $0M | 99% |
| Q2 2025 | 35 | +6.1% | 3.22% | 9.99 pp | $0M | 76% |
| Q1 2025 | 33 | 5.7% | 13.21% | +7.01 pp | $1M | +113% |
| Q4 2024 | 35 | 7.9% | 6.20% | 23.81 pp | $1M | 79% |
| Q3 2024 | 38 | 24% | 30.01% | 35.68 pp | $2M | 54% |
| Q2 2024 | 50 | +6.4% | 65.69% | +43.35 pp | $5M | +194% |
| Q1 2024 | 47 | 16% | 22.34% | 177.65 pp | $2M | 93% |
| Q2 2021 | 56 | — | 199.99% | — | $28M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying BCLI stock.
Based on Q3 2025 13F filings, institutional ownership of Brainstorm Cell Therapeutics Inc. stands at 0.0%, held across 5 reporting institutions.
ADVISOR GROUP HOLDINGS, INC. is the largest reported institutional holder of BCLI, with approximately 1,785 shares worth $0.00B as of Q3 2025.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of BCLI.
Our composite Smart Money Score for BCLI is 4 out of 100 (Heavy Distribution). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
0 institutions opened new positions in BCLI during Q3 2025, while 30 fully exited. 0 added to existing positions and 5 trimmed.
BCLI institutional ownership fell by 3.20 percentage points quarter-over-quarter, with a net change of -30 holders.
The top 10 institutions account for 100.0% of all reported 13F value in BCLI, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Brainstorm Cell Therapeutics Inc. (BCLI) Institutional Ownership